Joshua graduated with a B.S. in Computer Science, Pre-Medicine Track from Texas A&M University. He is a M.D./M.Eng. candidate at EnMed, and his prior work includes founding a medical-AI startup backed by NSF and interning as an AI engineer. As President of Sling Health, Joshua leads national digital strategy, public relations, and outreach efforts across multiple universities, securing funding and building partnerships.

Fouzul is a current M.D./M.Eng. candidate at EnMed with prior undergraduate study at Texas A&M University. She is engaged in med-tech innovation through Houston Methodist and leads outreach & development at Sling Health, connecting student innovators, external partners, and clinical stakeholders to advance med-tech ventures.

Dara holds a B.S. in Biological Sciences from Louisiana State University. He currently serves as a Research Specialist in the Department of Pathology & Laboratory Medicine at Emory University School of Medicine, where he contributes to translational biomedical research and publication-driven projects. He brings strong scientific foundations and leadership in medical-innovation operations to the board.

Minju Lee is an experienced leader with deep expertise in guiding early-stage innovation programs and overseeing strategic direction for growing organizations. He brings a strong background in operational leadership and ecosystem development.

Dean of the McKelvey School of Engineering at Washington University in St. Louis, providing leadership in engineering, innovation, research development, and academic-industry collaboration.

Vice Chancellor for Medical Education, offering expertise in curriculum design, clinical training pathways, program accreditation, and national medical education leadership.

CEO of Cognition Source, with experience leading companies focused on intelligent systems, algorithmic performance, and applied computational technologies.

CEO of OPCOMM, bringing expertise in operations management, engineering systems, communications technology, and product commercialization.

CEO of Absco Therapeutics, contributing experience in biotechnology leadership, therapeutic development, early-stage biotech strategy, and translational research.

Co-founder of AbscoTX, providing insight into startup formation, translational biotech, early-stage R&D, and entrepreneurial strategy.